The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15755195.
- Also identified by PMC identifier 1062889.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action
Medical subject headings
- Drug Industry
- Fraud
- Information Services